TCA
AGN

Taconic Capital Advisors’s Allergan plc AGN Stock Holding History

Taconic Capital Advisors’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-1,735,300
Closed -$307M – 82
2020
Q1 		$307M Buy
1,735,300
+275,300
+19% +$51.8M 18.03% 1
2019
Q4 		$279M Sell
1,460,000
-235,000
-14% -$42.4M 11.29% 2
2019
Q3 		$285M Buy
1,695,000
+1,540,000
+994% +$251M 17.83% 3
2019
Q2 		$26M Buy
+155,000
New +$21.5M 1.58% 16
2016
Q1 		– Sell
-30,000
Closed -$9.38M – 82
2015
Q4 		$9.38M Buy
+30,000
New +$8.93M 0.31% 42

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Taconic Capital Advisors's AGN Position: Q2 2020 in Review

Taconic Capital Advisors sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 1,735,300 shares — an estimated $307M sold.

Taconic Capital Advisors first reported a position in AGN in Q4 2015 and held it in 5 quarters. The position peaked at $307M in Q1 2020. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Taconic Capital Advisors reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Taconic Capital Advisors sold 1,735,300 Allergan plc shares in Q2 2020, an estimated $307M.
  • Taconic Capital Advisors first reported a position in Allergan plc in Q4 2015 and held it in 5 quarters.
  • Taconic Capital Advisors's Allergan plc position peaked at $307M in Q1 2020.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Taconic Capital Advisors's 13F filing for Q2 2020, filed 14 Aug 2020.